- Residency - UT Southwestern Medical Center (2007-2010), Internal Medicine
- Fellowship - UT Southwestern Medical Center (2011-2014), Hematology Oncology
- Medical School - UT Southwestern Medical School (2003-2007)
Ibrahim Ibrahim, M.D.
Director, Non-malignant Hematology Program
- Internal Medicine - Hematology/Oncology
Ibrahim Ibrahim, M.D., is an Assistant Professor of Internal Medicine at UT Southwestern, and a faculty member in the Division of Hematology and Oncology. His clinical interests include thrombosis, hemostasis, and thrombocytopenic disorders.
Dr. Ibrahim holds a bachelor’s degree in bioengineering from Rice University in Houston, Texas. He received his medical degree from UT Southwestern, where he remained to complete internal medicine residency training and fellowship training in hematology and oncology.
Prior to joining the UT Southwestern faculty in 2018, he was an Assistant Professor of Internal Medicine at Houston Methodist Hospital in the Texas Medical Center.
He is certified by the American Board of Internal Medicine in Internal Medicine, Hematology, and Medical Oncology.
Dr. Ibrahim’s research interests in blood disorders have resulted in multiple peer-reviewed publications and two book chapters, as well as presentations at professional and scientific conferences.
At UT Southwestern, Dr. Ibrahim serves as the director of the Non-Malignant Hematology Program, and as medical director of the Blood Disorders Clinic. He also serves as medical director of Parkland Hospital’s Benign Hematology Clinic.
His committee service includes UT Southwestern’s Pharmacy & Therapeutic Committee, on which he chairs the Anticoagulation Subcommittee, and the Data and Safety Monitoring Committee of the Harold C. Simmons Comprehensive Cancer Center.
Dr. Ibrahim is actively involved in several professional organizations, including the American Society of Hematology and the International Society on Thrombosis and Haemostasis.
During his free time, Dr. Ibrahim enjoys spending time with his family, playing tennis, reading, and traveling.
Immature platelets as a biomarker for disease severity and mortality in COVID-19 patients.
Welder D, Jeon-Slaughter H, Ashraf B, Choi SH, Chen W, Ibrahim I, Bat T, British journal of haematology 2021 Jun
Four Limb Ischemia: A Severe Case of Heparin Induced Thrombocytopenia.
Anand K, Ibrahim I, Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2019 Apr 35 2 397-398
Chronic myelomonocytic leukemia-related vasculitis mimicking giant cell arteritis.
Amin SD, Vickers A, Hong BY, Ponce CMP, Ibrahim IF, Chevez-Barrios P, Lee AG, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2019 Jun 54 3 e140-e145
Intravascular large B-cell lymphoma: an elusive diagnosis with challenging management.
Mukherjee A, Ibrahim IF, The Journal of community and supportive oncology 2018 16 6 e280-e282
Autosplenectomy in a Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH).
Burns E, Anand K, Acosta G, Irani M, Chung B, Maiti A, Ibrahim I, Rice L, Case reports in hematology 2019 2019 3146965
Sickle Cell Trait and Rhabdomyolysis among U.S. Army Soldiers.
Ibrahim IF, Rice L The New England journal of medicine 2016 10 375 17 1695-6
Intravenous Immunoglobulin for Heparin-Induced Thrombocytopenia.
Ibrahim IF, Rice L Chest 2017 Oct 152 4 906-907
- Immature platelets as a biomarker for disease severity and mortality in COVID-19 patients.
Results: 1 Locations